3
Announcements
Trials
Browse
Landscape
Status
Completed
19
Unknown
5
Recruiting
2
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
29
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Liver Neoplasms
1
Carcinoma, Hepatocellular
1
Interventions
Blood Specimen Collection
27
Surveys and Questionnaires
24
Magnetic Resonance Spectroscopy
10
Observation
7
Flow Cytometry
7
Specimen Handling
6
Amplified Fragment Length Polymorphism Analysis
6
exemestane
5
Radiotherapy
5
Magnetic Resonance Imaging
5
Immunoenzyme Techniques
5
Biopsy
5
Radiation
4
Neoadjuvant Therapy
4
Mental Status and Dementia Tests
4
Genetic Testing
4
Gene Expression Profiling
4
Electroporation
4
Data Collection
4
Bevacizumab
4
Trastuzumab
3
Tomography, X-Ray Computed
3
Tomography, Optical Coherence
3
Therapeutics
3
Surgical Procedures, Operative
3
Sunitinib
3
Sorafenib
3
Registries
3
Radiosurgery
3
Psychiatric Rehabilitation
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Observational
×
regorafenib
×
Clear all
NCT03644511
2020-08-21
SORAGO-HCC
Bayer
Terminated
3 enrolled